Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

ADP, a leading global technology company providing human capital management (HCM) solutions, has again been named by FORTUNE® magazine as one of the "World's Most Admired Companies" in 2025. This ...

“The new logo centres on the ‘K’ symbol ... Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after an earlier rejection.

Celebrities including Angela Yee, Brent Faiyaz, CeCe Winans and Pepa celebrated with St. Jude Celebration of Hope.

A systematic literature review found no evidence to support that physical exertion without rhabdomyolysis (muscle breakdown) or heat injury can cause sudden death for individuals with sickle cell ...

Vertex Pharmaceuticals Inc. (VRTX), a commercial-stage global biotechnology company, announced Friday a reimbursement agreement with ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

A controversial memoir of a Finnish woman who migrated to Stalin’s Soviet Russia in the 1930s and escaped in 1941. Ninety ...

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

If it’s been more than four hours and your hard-on isn’t going away, you could be suffering from priapism. It’s a serious ...